16th October 2021 | Pharma Updates
Wockhardt will make 500 mn mystery vaccines
The drugmaker will supply the vaccine to the principal innovator and they will launch the vaccine in India.
‘Industry-academia partnership in biotherapeutics research to address unmet demands’
Drug and biopharma companies are entering into partnerships with good universities for biotherapeutics research.
Another ITAT bench to govern drugmakers freebies
A two-member of the ITAT bench has directed larger bench should check whether the expenses on freebies to medical doctors
incurred by drugmakers should be allowed as a deduction.
Bulk drugs industry may see flurry of deals in future
Indian drug companies may see an unprecedented deals spree in next three months, with around six transactions worth over USD 1 bn in final negotiations, people aware of the matter said.
Cipla achieves spot in Forbes’ “World’s Best Employers 2021” list
Cipla is the only Indian drugmaker to secure a spot in the Forbes “World’s Best Employers 2021” list among the top global employers across 58 nations.
DRL launches Carmustine for injection, USP
DRL’s carmustine for injection, USP is a lyophilized powder as a packet which includes a vial containing 100-milligram carmustine USP and a vial containing 3- millilitre sterile diluent.
India again start Covid vaccine export
One million shots of Covaxin were transported to Iran last week.